Literature DB >> 20652270

Renal thrombotic microangiopathies/thrombotic thrombocytopenic purpura in a patient with primary Sjögren's syndrome complicated with IgM monoclonal gammopathy of undetermined significance.

Tomohiro Koga1, Satoshi Yamasaki, Hideki Nakamura, Atsushi Kawakami, Akira Furusu, Takashi Taguchi, Katsumi Eguchi.   

Abstract

Thrombotic microangiopathy (TMA)/thrombotic thrombocytopenic purpura (TTP) is a rare but potentially lethal condition requiring rapid recognition, diagnosis, and initiation of therapy. We experienced a case of a 61-year-old woman with primary Sjögren's syndrome (pSS) complicated with severe renal TMA/TTP following IgM monoclonal gammopathy of undetermined significance (MGUS). She was admitted to our hospital for further evaluation of hypergammaglobulinema, acute renal failure, and severe thrombocytopenia. She had been diagnosed with pSS 13 years prior to admission. Histological examination of her kidney revealed fibrin thrombi in the glomeruli and arterioles, a finding that is consistent with TMA/TTP. The patient was subsequently treated with plasma exchange, which resulted in a successful outcome without any complications. This rare case suggests that it is important to make a therapeutic decision based on appropriate and prompt pathological diagnosis.

Entities:  

Mesh:

Year:  2010        PMID: 20652270     DOI: 10.1007/s00296-010-1569-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  9 in total

Review 1.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

Authors:  W A Wilson; A E Gharavi; T Koike; M D Lockshin; D W Branch; J C Piette; R Brey; R Derksen; E N Harris; G R Hughes; D A Triplett; M A Khamashta
Journal:  Arthritis Rheum       Date:  1999-07

2.  Clinical and morphological features of kidney involvement in primary Sjögren's syndrome.

Authors:  N Bossini; S Savoldi; F Franceschini; S Mombelloni; M Baronio; I Cavazzana; B F Viola; B Valzorio; C Mazzucchelli; R Cattaneo; F Scolari; R Maiorca
Journal:  Nephrol Dial Transplant       Date:  2001-12       Impact factor: 5.992

Review 3.  Primary Sjögren syndrome: hematologic patterns of disease expression.

Authors:  Manuel Ramos-Casals; Jasep Font; Mario Garcia-Carrasco; Maria-Pilar Brito; Jose Rosas; Jaime Calvo-Alen; Lucio Pallares; Ricard Cervera; Miguel Ingelmo
Journal:  Medicine (Baltimore)       Date:  2002-07       Impact factor: 1.889

4.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

Review 5.  HUS and TTP: variable expression of a single entity.

Authors:  G Remuzzi
Journal:  Kidney Int       Date:  1987-08       Impact factor: 10.612

Review 6.  Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

Review 7.  The antiphospholipid syndrome.

Authors:  Michael J Fischer; Joyce Rauch; Jerrold S Levine
Journal:  Semin Nephrol       Date:  2007-01       Impact factor: 5.299

Review 8.  Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113

9.  Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance.

Authors:  Davide Rossi; Lorenzo De Paoli; Silvia Franceschetti; Daniela Capello; Chiara Vendramin; Monia Lunghi; Annarita Conconi; Corrado Magnani; Gianluca Gaidano
Journal:  Br J Haematol       Date:  2007-05-29       Impact factor: 6.998

  9 in total
  7 in total

1.  Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.

Authors:  Larissa Higgins; Samih H Nasr; Samar M Said; Prashant Kapoor; David Dingli; Rebecca L King; S Vincent Rajkumar; Robert A Kyle; Taxiarchis Kourelis; Morie A Gertz; Angela Dispenzieri; Martha Q Lacy; Francis K Buadi; Stephen M Ansell; Wilson I Gonsalves; Carrie A Thompson; Fernando C Fervenza; Ladan Zand; Yi L Hwa; Dragan Jevremovic; Min Shi; Nelson Leung
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-30       Impact factor: 8.237

Review 2.  Sjögren's syndrome initially presented as thrombotic thrombocytopenic purpura in a male patient: a case report and literature review.

Authors:  Xiaohan Xu; Tienan Zhu; Di Wu; Lu Zhang
Journal:  Clin Rheumatol       Date:  2017-11-13       Impact factor: 2.980

Review 3.  Extra-renal manifestations of complement-mediated thrombotic microangiopathies.

Authors:  Johannes Hofer; Alejandra Rosales; Caroline Fischer; Thomas Giner
Journal:  Front Pediatr       Date:  2014-09-08       Impact factor: 3.418

4.  Renal and pulmonary thrombotic microangiopathy triggered by proteasome-inhibitor therapy in patient with smoldering myeloma: A renal biopsy and autopsy case report.

Authors:  Clarissa A Cassol; Michael P A Williams; Tiffany N Caza; Sophia Rodriguez
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 5.  Thrombotic Microangiopathy, an Unusual Form of Monoclonal Gammopathy of Renal Significance: Report of 3 Cases and Literature Review.

Authors:  Edward J Filippone; Eric D Newman; Li Li; Rakesh Gulati; John L Farber
Journal:  Front Immunol       Date:  2021-11-10       Impact factor: 7.561

6.  Cyclophosphamide-rescued plasmapheresis-unresponsive secondary thrombotic thrombocytopenic purpura caused by Sjögren's syndrome.

Authors:  Ting-Yun Lin; Chun-Cheng Chang; Chun-Chao Chang; Jui-Yu Yuan; Hsi-Hsien Chen
Journal:  Arch Med Sci       Date:  2012-10-08       Impact factor: 3.318

Review 7.  Longitudinal extensive transverse myelitis with an abnormal uFLC ratio in a pediatric patient: Case report and literature review.

Authors:  Po-Chang Hsu; Shyi-Jou Chen
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.